Respiratory and skin health among glass microfiber production workers: a cross-sectional study.
BACKGROUND
Only a few studies have investigated non-malignant respiratory effects of glass microfibers and these have provided inconsistent results. Our objective was to assess the effects of exposure to glass microfibers on respiratory and skin symptoms, asthma and lung function.


METHODS
A cross-sectional study of 102 workers from a microfiber factory (response rate 100%) and 76 office workers (73%) from four factories in Thailand was conducted. They answered a questionnaire on respiratory health, occupational exposures, and lifestyle factors, and performed spirometry. Measurements of respirable dust were available from 2004 and 2005.


RESULTS
Workers exposed to glass microfibers experienced increased risk of cough (adjusted OR 2.04), wheezing (adjOR 2.20), breathlessness (adjOR 4.46), nasal (adjOR 2.13) and skin symptoms (adjOR 3.89) and ever asthma (adjOR 3.51), the risks of breathlessness (95%CI 1.68-11.86) and skin symptoms (1.70-8.90) remaining statistically significant after adjustment for confounders. There was an exposure-response relation between the risk of breathlessness and skin symptoms and increasing level of microfiber exposure. Workers exposed to sensitizing chemicals, including phenol-formaldehyde resin, experienced increased risk of cough (3.43, 1.20-9.87) and nasal symptoms (3.07, 1.05-9.00).


CONCLUSIONS
This study provides evidence that exposure to glass microfibers increases the risk of respiratory and skin symptoms, and has an exposure-response relation with breathlessness and skin symptoms. Exposure to sensitizing chemicals increased the risk of cough and nasal symptoms. The results suggest that occupational exposure to glass microfibers is related to non-malignant adverse health effects, and that implementing exposure control measures in these industries could protect the health of employees.
Sripaiboonkij
Penpatra
P
Institute of Occupational and Environmental Medicine, University of Birmingham, Edgbaston, Birmingham, UK. sripaiboonkijpor@hotmail.com
Sripaiboonkij
Nintita
N
Phanprasit
Wantanee
W
Jaakkola
Maritta S
MS
D000395:Air Pollutants, Occupational / Q000633:toxicity*; D003430:Cross-Sectional Studies; D005898:Glass; D006304:Health Status; D016273:Occupational Exposure / Q000706:statistics & numerical data; D012140:Respiratory Tract Diseases / Q000453:epidemiology*; D012871:Skin Diseases / Q000453:epidemiology*; D011795:Surveys and Questionnaires
D000395:Air Pollutants, Occupational
Chest. 1989 Aug;96(2):297-300
2666043
Environ Health Perspect. 2000 Aug;108 Suppl 4:665-74
10931785
Am J Epidemiol. 2003 Nov 15;158(10):981-7
14607806
J Med Assoc Thai. 2000 May;83(5):457-66
10863890
Int J Dermatol. 2000 May;39(5):372-4
10849131
Contact Dermatitis. 1993 Sep;29(3):119-27
8222622
Contact Dermatitis. 2002 Dec;47(6):329-33
12581277
Int Arch Occup Environ Health. 1988;61(3):171-8
2851556
Ind Health. 2002 Jan;40(1):42-50
11926514
Am J Epidemiol. 2006 Oct 15;164(8):742-9
16877535
Br J Ind Med. 1993 Aug;50(8):717-25
8398858
IARC Monogr Eval Carcinog Risks Hum. 2002;81:1-381
12458547
Eur Respir J. 1995 Dec;8(12):2149-73
8666112
Regul Toxicol Pharmacol. 2005 Nov;43(2):181-93
16099571
Environ Health Perspect. 2002 May;110(5):543-7
12003761
Occup Environ Med. 2009 Jul;66(7):442-7
19188201
Am J Public Health. 2003 Dec;93(12):2055-60
14652334
Occup Environ Med. 1999 Sep;56(9):612-7
10615294
J Soc Occup Med. 1985 Winter;35(4):121-7
3878434
Am J Ind Med. 1996 Jan;29(1):3-13
8808037
Am J Respir Crit Care Med. 1995 Sep;152(3):1107-36
7663792
Eur Respir J. 2008 Apr;31(4):807-14
18032440
Environ Health Perspect. 2006 Nov;114(11):1725-9
17107859
Environ Health Perspect. 2007 Jul;115(7):1007-11
17637914
Br J Ind Med. 1992 Oct;49(10):714-20
1419860
J Allergy Clin Immunol. 2006 Mar;117(3):642-8
16522465
J Soc Occup Med. 1978 Oct;28(4):134-41
713506